Development of a fluorescence-based assay for RecBCD activity using functional data analysis and design of...

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Biochemical assay optimization is crucial but challenging due to numerous interacting variables.
• Traditional methods like 'one-factor-at-a-time' are inefficient and fail to explore variable interactions.
• Design of Experiments (DoE) offers a more efficient approach for simultaneous multi-variable optimization.

Purpose of the Study:

• To optimize a novel fluorescence-based assay for the bacterial enzyme RecBCD.
• To apply Design of Experiments (DoE) and Functional Data Analysis (FDA) for efficient assay development.
• To identify optimal assay conditions for drug screening against RecBCD.

Main Methods:

• Application of Design of Experiments (DoE) to systematically vary assay parameters.
• Utilized Functional Data Analysis (FDA) to model and predict enzyme reaction curve shapes.
• Developed a new fluorescence-based assay for the RecBCD enzyme complex.

Main Results:

• DoE successfully identified optimal conditions for the RecBCD assay by exploring multiple variables simultaneously.
• FDA effectively predicted assay performance across various input combinations.
• The optimized assay proved suitable for high-throughput drug screening.

Conclusions:

• A novel, optimized fluorescence-based assay for the antibiotic target RecBCD was successfully developed.
• DoE and FDA significantly accelerate biochemical assay development and optimization.
• This approach enhances efficiency in identifying conditions for drug discovery efforts.